Palau vs Sweden: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Palau
95.0%
in 2025
Sweden
95.0%
in 2025
Palau rank
37th
Sweden rank
37th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Palau
- Sweden
How they compare
Palau currently reports 95.0% against 95.0% in Sweden, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Sweden ahead.
Palau ranks 37th and Sweden ranks 37th of 192 countries.
Sweden has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Palau | Sweden | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 12.5% | 79.0% | 66.5% | Sweden |
| 2010s | 81.2% | 97.5% | 16.3% | Sweden |
| 2020s | 86.0% | 95.2% | 9.2% | Sweden |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Palau or Sweden?
- Palau, at 95.0% against 95.0% in Sweden as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Palau and Sweden?
- 0.0%, with Palau ahead.
- How many years of comparable data are there for Palau and Sweden?
- 18 years are reported by both, from 2008 to 2025.
- How do Palau and Sweden rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Palau ranks 37th and Sweden ranks 37th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.